![Nicholas Haft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Haft
Fundador en
Delix Therapeutics, Inc.
.
Perfil
Nicholas Haft is the founder of Delix Therapeutics, Inc. Mr. Haft is currently the Director at Arcos Ventures SPV LLC since 2015.
Formerly, Mr. Haft was an Independent Director at Finch Therapeutics Group, Inc. from 2020 to 2023.
Mr. Haft completed undergraduate education at The Wharton School of the University of Pennsylvania.
Cargos activos de Nicholas Haft
| Empresas | Cargo | Inicio |
|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Fundador | - |
Arcos Ventures SPV LLC | Director Ejecutivo | 01/04/2015 |
Antiguos cargos conocidos de Nicholas Haft.
| Empresas | Cargo | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director/Miembro de la Junta | 23/06/2023 |
Formación de Nicholas Haft.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
27
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Arcos Ventures SPV LLC | |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas Haft
